Latest Ulcerative colitis Stories
CLEVELAND, Nov. 29, 2010 /PRNewswire-FirstCall/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today publically congratulated its sponsor partner Cosmo Pharmaceuticals S.p.A. (SIX: COPN) who last week announced positive top-line results from their second pivotal Phase III clinical study which was conducted in the EU utilizing DATATRAK's unified eClinical product suite and services team...
New interactive components lead to better Crohn's disease and ulcerative colitis education and disease management NEW YORK, Nov. 15, 2010 /PRNewswire-USNewswire/ -- The Crohn's & Colitis Foundation of America today announced the launch of new enhancements and resources to its online community (www.ccfacommunity.org). Developed to meet the dynamic needs of patient groups, this site serves as a free resource to provide patients and families with the vital peer support they need in...
Helicobacter pylori in the mouse stomach put the brakes on colitis by reducing the immune response in the lower GI tract, U-M study showsHelicobacter pylori, a common stomach bacterium, reduced the severity of inflammation of the colon caused by Salmonella in mice, according to research from U-M Medical School scientists.More than half the people in the world are infected with H. pylori, although it is very unusual to find it in the United States. But this research shows there may be an...
WOLLERAU, Switzerland, November 1, 2010 /PRNewswire/ -- - AOP Orphan to Make Strategic EUR3m Investment in Shield Holdings Shield Holdings AG (Shield), the independent specialty pharmaceutical company focused on the development and commercialisation of late-stage hospital pharmaceuticals, today announces that it has signed a strategic commercialisation agreement for its lead asset, ST10-021, an iron therapy product which has commenced Phase III clinical development, with AOP...
MOUNTAIN VIEW, Calif., Oct. 27 /PRNewswire/ -- ChemoCentryx, Inc., today announced that it reported one-year results from the Company's PROTECT-1 Study (the Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial) of Traficet-EN(TM) (CCX282-B) in patients with moderate-to-severe Crohn's disease. Traficet-EN, an orally bioavailable CCR9-specific chemokine receptor antagonist showed clinical efficacy in a 12-week Induction period, as well as a 36-week Maintenance period....
The Crohn's & Colitis Foundation today announced that Bob Van Dillen, meteorologist for HLN's "Morning Express with Robin Meade," will again serve as honorary Chairman of its endurance training and fundraising program, Team Challenge (http://www.ccteamchallenge.org). As Honorary Chairman, Van Dillen is training for the December 5th Zappos.com Rock "˜n' Roll Las Vegas Half Marathon and raising crucial dollars for the Foundation's research, education, and support services. New York, NY...
At the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, Texas, several studies of the effectiveness of non"X"ray techniques to evaluate Crohn's disease revealed that diagnostic strategies such as capsule endoscopy (CE) and magnetic resonance enteroscopy (MRE) are useful in managing patients with inflammatory bowel disease (IBD) and avoiding ionizing radiation.IBD Patients Exposed to Significant Ionizing RadiationRadiographic imaging is an...
Vital that those caring for IBD patients evaluate for vitamin D nutritional deficiencyVitamin D deficiency puts patients with Inflammatory Bowel Disease (IBD) at greater risk of osteoporosis, osteopenia and an overall higher rate of abnormal bone density, according to the results of a new study unveiled today at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, Texas.The study, "Vitamin D Deficiency and Abnormal DEXA Scans in Inflammatory...
SKILLMAN, N.J., Oct. 15 /PRNewswire/ -- The Great Comebacks® Program announced today the 2010 regional awards recipients. Now in its 26th year, the annual Great Comebacks® Program recognizes the inspirational achievements of people who have overcome serious intestinal diseases, colorectal cancer and other conditions that can lead to ostomy surgery. (Logo: http://photos.prnewswire.com/prnh/20080227/NYW005LOGO ) (Logo: http://www.newscom.com/cgi-bin/prnh/20080227/NYW005LOGO ) The...
Researchers at the Georgia Institute of Technology and Emory University have developed a novel approach for delivering small bits of genetic material into the body to improve the treatment of inflammatory bowel diseases. Delivering short strands of RNA into cells has become a popular research area because of its potential therapeutic applications, but how to deliver them into targeted cells in a living organism has been an obstacle.In the Oct. 10 advance online edition of the journal Nature...
